Trial Profile
A Phase 1 Safety and Intrapulmonary Pharmacokinetics Study of ZTI-01 (Intravenous Fosfomycin Disodium) in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Oct 2023
Price :
$35
*
At a glance
- Drugs Fosfomycin (Primary)
- Indications Bacterial infections; Nosocomial pneumonia; Pneumonia
- Focus Adverse reactions; Pharmacokinetics
- 23 Dec 2020 Status changed from recruiting to completed.
- 25 Nov 2020 Status changed from suspended to recruiting.
- 23 Jul 2020 Planned End Date changed from 30 Jun 2020 to 1 Dec 2020.